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the Netherlands.BACKGROUND Response to cardiac resynchronization therapy
(CRT) remains challenging. Pacing from multiple sites of the left
ventricle (LV) has shown promising results.
OBJECTIVE The purpose of this study was to systematically
compare the acute hemodynamic effects of multipoint pacing
(MPP) by means of a quadripolar lead with conventional biven-
tricular (BiV) pacing.
METHODS Twenty-nine patients (23 men; mean age 72 12 years;
LV ejection fraction 29%  7%; 15 with ischemic cardiomyopathy,
17 with left bundle branch block; mean QRS 183  23 ms)
underwent CRT implantation. Per patient, 3.2 1.2 different veins
and 6.3  2.4 pacing sites were tested. LV electrical delay (Q-LV)
was measured at each location, along with the increase in LV dP/
dtmax (maximum rate of rise of LV pressure) obtained by BiV and
MPP. The effect of MPP, by means of simultaneous pacing from
distal and proximal dipoles, was investigated at all available sites.
RESULTS Overall, 3.2  1.2 different MPP measurements were
collected per patient. When all sites were considered, LV dP/dtmax
increased from 951 193 mm Hg/s at baseline to 1144 255 and
1178 259 mm Hg/s on BiV and MPP, respectively. When the best
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mm Hg/s (MPP). The mean QRS duration at any site during MPP and
conventional CRT was 171  18 and 175  16 ms (P ¼ .003),
respectively.
CONCLUSION Compared with BiV pacing at any LV site, MPP
yielded a small but consistent increase in hemodynamic response.
A correlation between the increase in hemodynamics and Q-LV on
MPP was observed for all measurements, including those taken at
the best and worst sites. The MPP-induced improvement in
contractility was associated with signiﬁcantly greater narrowing
of the QRS complex than conventional BiV pacing.
KEYWORDS Cardiac resynchronization therapy; Multipoint pacing;
Hemodynamics
ABBREVIATIONS BiV ¼ biventricular; CRT ¼ cardiac
resynchronization therapy; HF ¼ heart failure; ICM ¼ ischemic
cardiomyopathy; LBBB ¼ left bundle branch block; LV ¼ left
ventricle; MPP ¼ multipoint pacing; PNS ¼ phrenic nerve
stimulation.
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Cardiac resynchronization therapy (CRT) is effective in
reducing heart failure (HF) symptoms and mortality and
improving quality of life.1,2 A favorable response to CRT,
however, is not achieved in approximately one third of
patients because of anatomic difﬁculties, the presence of
phrenic nerve stimulation (PNS), high pacing thresholds, lefthttp://dx.doi.org/10.1016/j.hrthm.2015.01.034
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ing of the LV lead.
These problems can be overcome by new implantation
techniques. The introduction of quadripolar technology (an
LV lead with 4 different pacing electrodes and a dedicated
device with multiple pacing options) has helped to avoid or
signiﬁcantly reduce the risk of PNS, high pacing threshold,
and lead instability.3 To increase the effectiveness of CRT,
several authors4,5 have evaluated the feasibility and effects of
multiple LV site pacing and have investigated the hypothesis
that pacing the LV over a wider area might provide more
effective resynchronization.
A new approach that involves the pacing of multiple sites
within the same coronary sinus vein by means of a single
quadripolar lead (multipoint pacing, or MPP; St. Jude
Medical, Sylmar, CA) has been suggested recently. Prelimi-
nary studies have investigated the effect of MPP by
comparing the changes in LV dP/dtmax (maximum rate of
rise of LV pressure),6 pressure-volume loop,7 global peak
LV radial strain, and LV outﬂow tract velocity time
intergral8 induced by biventricular (BiV) pacing and MPP
in a single coronary sinus branch. Small, variable improve-
ments have been reported, sometimes with the use of
different pacing vectors in the same patient. Although the
results of these studies have generally been positive, they do
not enable us to predict the best MPP algorithm or
combination of sites at any given location, not least because
the working mechanism of MPP is not exactly known.
In a previous study, we found a direct relation between
Q-LV and hemodynamic improvement during conventional
BiV pacing, which indicates that pacing at the latest activated
site provides the best hemodynamic effect.9 Our hypothesis
was that the beneﬁt of MPP was derived from better
resynchronization. To study this, we systematically inves-
tigated the hemodynamic beneﬁt of MPP performed at many
pacing sites per heart and related the hemodynamic effect to
both Q-LV and the reduction in QRS duration.Methods
Twenty-nine consecutive candidates for CRT with indica-
tions for the implantation of a CRT-deﬁbrillator or CRT-
pacemaker with LV quadripolar lead technology were
enrolled in a prospective study. The local ethics board
approved the study, and all patients provided written
informed consent.
Right ventricular leads were implanted in the midseptum
and atrial leads were implanted in the right atrial appendage,
according to our standard implantation procedure. A pre-
viously described telescopic approach10 was used for can-
nulation of the coronary sinus and subcannulation of all
suitable collateral veins; this approach allows continuous
selective navigation with angiographic visualization. All
veins that were actually cannulated and then targeted with
the LV quadripolar pacing lead (Quartet, St. Jude Medical)
were deﬁned as available veins. We did not collect data on
veins that were visualized but not cannulated. Pacing siteswere classiﬁed in accordance with the scheme suggested by
Singh et al11 in the MADIT-CRT (Multicenter Automatic
Deﬁbrillator Implantation Trial–Cardiac Resynchronization
Therapy) analysis. In the left anterior oblique view, the short
axis of the heart was divided into anterior, anterolateral,
lateral, posterolateral, and posterior segments. To classify the
single LV sites, the long axis of the heart was divided into
basal, mid, and apical ventricular segments in the right
anterior oblique view. To classify MPP sites, the long axis
was divided into only 2 segments: midapical and midbasal.
The study protocol was designed to assess, at each pacing
site, the intrinsic Q-LV interval, the paced QRS width and
LV dP/dtmax during standard BiV pacing, and the paced QRS
width and LV dP/dtmax during MPP. Standard BiV pacing
was performed in the bipolar conﬁguration with the 2 distal
electrodes of the quadripolar lead (interdipole length 20 mm)
or the 2 proximal electrodes of the lead (interdipole length 17
mm). MPP stimulation was performed by means of simulta-
neous pacing from the 2 dipoles.
Electrophysiology laboratory measurements
Spontaneous and paced QRS durations and Q-LV intervals
were measured by means of a Bard LabSystem PRO EP
V2.4a (C.R. Bard Inc, Lowell, MA) with high-resolution
electronic calipers at a display speed of 100 mm/s. The paced
QRS duration was measured from the beginning of the
ventricular pacing spike to the end of the QRS complex as
the maximum paced QRS duration in any of the 12 ECG
leads.12 The Q-LV interval was deﬁned as the interval from
the onset of the intrinsic QRS on the surface ECG to the ﬁrst
large positive or negative peak of the LV electrogram.13
In patients with sinus rhythm, BiV pacing and MPP were
performed in the VDD mode (with a ﬁxed atrioventricular
delay of 130 ms). The VV interval was always set to 0 ms. In
patients with atrial ﬁbrillation, VVI pacing was performed at
a rate 5 to 10 beats above the intrinsic ventricular rate.14
All pacing conﬁgurations were performed by means of a
triple-chamber pacing system analyzer (Merlin EX3100
PSA, St. Jude Medical). During MPP, the LV1 (D1-M2
conﬁguration) and LV2 (M3-P4 conﬁguration) were paced
simultaneously from the LV output of the pacing system
analyzer by means of a custom-made epsilon-shaped adapter.
To ensure capture, pulse exit was programmed at the double
of the highest pacing threshold of the 2 dipoles. Moreover, to
ensure capture recording, we always checked an ECG 12-
lead tracing on the electrophysiology system in each pacing
conﬁguration, single distal and proximal dipole and quad-
ripolar. We never observed a signiﬁcant difference in
impedance between the 2 dipoles that could affect capture.
Therefore, for the purpose of this study, the LV1-LV2 delay
was 0 ms.
Acute hemodynamic measurements
Measurements of LV dP/dtmax were taken with a Pressur-
eWire Certus and PhysioMon software (St. Jude Medical
Systems AB, Uppsala, Sweden). The guide was inserted
Table 1 Patient characteristics
Variable
Total population, n 29
ICM, n (%) 18 (62)
Age, years 72  12
Male, n (%) 23 (79)
NYHA class II/III, n (%) 5 (17)/24 (83)
SR/AF, n (%) 19; 66 % / 10; 34%
LVEF, % 29  7
QRS, ms 183  23
LBBB, n (%) 19 (66)
RBBB, n (%) 6 (21)
IVCD, n (%) 2 (7%)
PM dependent, n (%) 2 (7%)
QRS morphology was classiﬁed according to American Heart Association/
American College of Cardiology Foundation/Heart Rhythm Society guide-
lines.16
AF ¼ atrial ﬁbrillation; ICM ¼ ischemic cardiomyopathy; IVCD ¼
intraventricular conduction delay; LBBB ¼ left bundle branch block;
LVEF ¼ left ventricular ejection fraction; NYHA ¼ New York Heart Association;
PM ¼ pacemaker; RBBB ¼ right bundle branch block; SR ¼ sinus rhythm.
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multipurpose catheter. The tip of the pressure wire was
placed in a stable LV position.
LV dP/dtmax at baseline and during the different pacing
protocols was calculated over an interval of 15 seconds;
premature ventricular contractions were eliminated electroni-
cally. A period of Z30 seconds was allowed to elapse after
any change in pacing settings or lead position to allow
hemodynamic stabilization. To minimize the impact of
respiration and physiological variation, each 15-second LV
dP/dtmax value was measured during 3 separate recordings
for each test conﬁguration.15
Statistical analysis
Our aim was to evaluate the improvement in ventricular
function obtained by switching the cardiac pacing protocol
from single-site BiV pacing to MPP in the same subject in a
1-arm (intrapatient) study. The instrumental data collected
were tabulated along with topographic and protocol infor-
mation and patients’ clinical characteristics.
We used repeated-measures analysis of variance to
estimate variations in within-subject measurements of LV
dP/dtmax and QRS and in the between-subject effects of left
bundle branch block (LBBB) and ischemic cardiomyopathy
(ICM) and their interactions; the Greenhouse-Geisser adjust-
ment was applied to degrees of freedom, and equal weights
were attributed to measurements. The Bonferroni correction
was used for pairwise planned comparisons between the
pacing protocols.
The analyses were conducted on all measurements
collected from patients (184 measurements) and on the
subsets “best measurement” and “worst measurement” (29
measurements, 1 for each patient). In each patient, the best
and worst measurement sites corresponded to the LV site
with the greatest and least improvement in LV dP/dtmax,
respectively, during BiV pacing vs baseline conditions.
Results
CRT devices were successfully implanted in 29 HF patients.
No complications related to the procedure were reported.
Mean procedural time was 159  24 minutes, and total
ﬂuoroscopy time was 31  7 minutes. The characteristics of
the patient population are shown in Table 1.
The data required for the study were available in all 29
patients. Overall, 184 single-site measurements (mean 6.3
2.4 per patient) were taken and a total of 92 (mean 3.2 1.2
per patient) different MPP conﬁgurations were tested in a
global setting of 92 veins (mean 3.2  1.2 per patient). A
mean of 3.2  1.2 veins per patient were cannulated,
whereas the mean number of veins not suitable for cannu-
lation was 0.28  0.45 veins per patients (in 8 patients, 5
veins because of small size and 3 veins for tortuosity). When
all sites were considered, LV dP/dtmax at baseline, during
BiV pacing, and during MPP was 951  193, 1144  255,
and 1178 259 mm Hg/s, respectively. For each patient, weselected the best and worst measurement, that is, the value at
the LV site with the greatest and least improvement in LV
dP/dtmax during BiV pacing vs baseline conditions. With
regard to the best measurement, LV dP/dtmax at baseline,
during BiV pacing, and during MPP was 942 202, 1200
267 (4.9% relative gain for mean of best vs all measure-
ments), and 1231  267 mm Hg/s (4.5% relative gain for
mean of best vs all measurements), respectively; with regard
to the worst measurement, these values were 957  216,
1093  284, and 1117  277 mm Hg/s, respectively.
Figure 1 shows this gain in within-subject measurements of
LV dP/dtmax for all measurements (Figure 1A) (F ¼ 191.01,
P o .001) and in the best and worst measurements
(Figure 1B) (F ¼ 95.19, P o .01).
The anatomic distribution of the effects of MPP vs BiV
pacing in terms of improvement in LV dP/dtmax is reported in
Figure 2. In all segments, MPP yielded a greater improve-
ment than BiV pacing. The segments displaying more than
20% beneﬁt were posterior-basal, posterior-apical and lat-
eral-apical; the anterolateral basal and apical segments
showed 15%–20% beneﬁt, whereas the remaining segments
beneﬁtted less than 15%.
Figure 3 shows the relationship between Q-LV and
hemodynamic improvement; an increase in LV dP/dtmax
corresponded signiﬁcantly to a progressive increase in Q-
LV. As depicted in Figure 3, the regression line for MPP was
higher than for conventional BiV pacing.
Figure 4 reports an example of the measurements taken on
each patient.
When the protocols were switched, no statistically sig-
niﬁcant difference in the change in LV dP/dtmax was
observed between LBBB patients and non-LBBB patients
(between-subject effect of LBBB: F ¼ 0.11, P ¼ .742) nor
between patients with or without ICM (between-subject
effect of non-ICM factor: F ¼ 0.092, P ¼ .762).
Figure 1 Gain in within-subject measurements of left ventricular (LV) dP/dtmax and pairwise comparisons between pacing protocols. A: Gain in LV dP/dtmax
during biventricular (BIV) and multipoint pacing (MPP) pacing protocols vs baseline (considering all pacing sites, 92 measurements). B: Gain in LV dP/dtmax
during BIV pacing and MPP protocols vs baseline (considering the “best” and “worst” measurements, 29 measurements each).
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Among all 29 patients, the baseline mean QRS width was
183  23 ms. During BiV pacing and MPP, the mean QRS
width was 175 16 and 171 18 ms, respectively. Figure 5
reports the effects of BiV pacing and MPP on QRS width.
The effects of BiV pacing and MPP on QRS width were
seen to differ in LBBB and non-LBBB patients (P ¼ .006).
In the LBBB group, QRS width at baseline and during BiV
pacing and MPP was 179 21, 173 16, and 168 18 ms,
respectively. In the non-LBBB group, QRS width at baseline
and during BiV pacing and MPP was 196  22, 178  9,
and 178  10 ms, respectively.
No statistically signiﬁcant difference was found between
non-ICM and ICM patients (P ¼ .774). In the non-ICM
group, QRS width at baseline and during BiV pacing and
MPP was 188  22, 170  16, and 168  20 ms,Figure 2 Anatomic distribution of the effects of multipoint pacing (MPP)
vs biventricular (BiV) pacing in terms of improvement in left ventricular
(LV) dP/dtmax in all patients. The number inside each segment indicates the
number of MPP sites used for measurements, and the color indicates the
mean percentage increase in LV dP/dtmax on MPP vs BiV pacing (relative
percentage increase is deﬁned as the percentage increase in LV dP/dtmax on
MPP in relation to the percentage increase from baseline to BiV).respectively. In the ICM group, QRS width at baseline and
during BiV pacing and MPP was 180  21, 177  15,
and172  17 ms, respectively.
PNS was found in 5 patients (17% of the patient
population). This was evaluated in all patients but was never
associated with the best position.Discussion
Our single-center study showed that MPP yielded a small but
consistent increase in hemodynamic response compared with
BiV pacing at any LV site. Moreover, we found that the
MPP-induced improvement in contractility was associated
with signiﬁcantly greater narrowing of the QRS complex
than with conventional BiV pacing.Figure 3 Relationship between electrical delay (Q-LV) and hemody-
namic improvement. Dispersion points graph of left ventricular (LV) dP/
dtmax and Q-LV interval at various sites in all subjects, along with the
common regression line (estimated by generalized linear mixed model)
between Q-LV interval and the resulting relative increment in LV dP/dtmax,
for both multipoint pacing (MPP; dotted line) and biventricular pacing (BIV;
solid line). Solid circles represent measurements corresponding to BIV
pacing; open circles indicate MPP.
Figure 4 Example of the measurements taken on each patient. This is the
case of a 32-year-old man with nonischemic cardiomyopathy, New York
Heart Association class III, sinus rhythm, left ventricular (LV) ejection
fraction 22%, left bundle branch block, and QRS 214 ms. A: Schematic
representation of the venous anatomy; 3 veins and 6 pacing sites were tested.
B: Correlation between percentage increase in LV dP/dtmax and Q-LV
interval. C: Correlation between percentage increase in LV dP/dtmax and
QRS narrowing. Solid symbols indicate measurements corresponding to
biventricular pacing (BIV); open symbols, multipoint pacing (MPP).
Figure 5 Effects of biventricular (BIV) and multipoint pacing (MPP) on
QRS width: QRS narrowing during BIV and MPP pacing protocols vs
baseline (considering all pacing sites).
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totally understood. Pacing from multiple LV sites has been
shown to offer further beneﬁts over conventional single-site
pacing in terms of better remodeling and better clinical
outcome.4,5 The underlying mechanism could be that of
improved and more uniform conduction.17
Initial experiences4,5 with 2-lead (multisite) pacing
revealed some advantages but also highlighted the potential
disadvantages of this approach, which include the need to
position another lead and such theoretical consequences asprolonged procedure, the risk of dislodgment, higher infec-
tion rates, and lead-related complications in general.
Recently, quadripolar lead technology has shown the same
feasibility and reliability as conventional bipolar technology
while offering advantages in terms of fewer lead complica-
tions, such as PNS and high thresholds.3 Moreover, some
authors have underscored the potential beneﬁts of pacing
from a more basal portion of the LV rather than from the
apical position, which is commonly adopted when bipolar
leads are used.11,18
Quadripolar technology has evolved to provide pacing
over a wider area of the LV by means of the same lead. The
pathophysiological basis of this development lies in the
electrical delay along a single vein, and modiﬁcation of this
delay could further increase the beneﬁt of CRT.7
Recent data6–8 have demonstrated the feasibility of MPP
and have indicated that it yields an acute hemodynamic
beneﬁt and better recovery from dyssynchrony. Indeed, in 32
of 42 HF patients (76%) who had received a CRT device,
Pappone et al7 found an improvement in LV dP/dtmax on
MPP over the improvement obtained by a standard BiV
conﬁguration using a pressure-volume loop system and a
complex pacing protocol. Using the same method of
determining LV dP/dt, Thibault et al6 reported similar
results, that is, an 84% increase in LV dP/dtmax on pacing
from the best multisite conﬁguration over and above the
increase yielded by BiV pacing in 19 patients. Moreover,
Rinaldi et al8 found a signiﬁcant improvement in acute
cardiac contractility and hemodynamics in 40 patients with
MPP compared with conventional CRT, as assessed by
echocardiographic indexes.
We analyzed the adjunctive value of MPP compared with
the best bipolar conﬁguration in 29 patients. Our results
conﬁrm previous data in terms of acute hemodynamic
improvements. With MPP, 26 of 29 patients (90%) had a
higher LV dP/dtmax than with conventional bipolar pacing at
the LV pacing site with the best BiV pacing results. Unlike
previous studies, we analyzed all the veins that could be
Heart Rhythm, Vol 12, No 5, May 2015980cannulated, not just the one that was generally considered the
target vein. Moreover, our results conﬁrmed the superiority
of pacing over a wide area of the LV by means of the same
lead in all of the veins that could actually be cannulated. The
novelty of our data lies in the fact that they demonstrated that
in 90% of veins, MPP achieved a greater hemodynamic
improvement than bipolar pacing. We did not ﬁnd any
signiﬁcant correlation between hemodynamic improvement
and anatomic LV sites. It could be speculated that there are
no deﬁnite prespeciﬁed or a priori best LV sites, despite the
observations of large clinical trials such as MADIT-CRT, in
which the apical position was considered to be the worst site.
There are few data on QRS narrowing after CRT in the
literature, and these are controversial. We found a signiﬁcant
QRS narrowing after CRT, and a further signiﬁcant narrow-
ing after MPP.
The relationship between QRS duration during CRT and
the clinical beneﬁt of CRT is an old issue and has been amply
reviewed. From a pathophysiological point of view, QRS
shortening after CRT should suggest better resynchroniza-
tion; however, the available data are discordant. In 139
recipients of CRT devices, Lecoq et al19 found that the only
independent predictor of response to CRT was the degree of
QRS shortening. Analogously, we observed a signiﬁcant
reduction in QRS duration during conventional BiV pacing
in our study population, which probably reﬂected their
improved cardiac efﬁciency. On the other hand, the further
increase in cardiac contractility elicited by MPP led to a
signiﬁcant additional reduction in QRS duration. The fact
that QRS shortening was observed in both LBBB and non-
LBBB patients strengthens the concept of improved global
function.
Several data20 have indicated a better outcome in patients
with LBBB and with nonischemic cardiomyopathy. By
contrast, our ﬁndings on acute hemodynamic response
appear to conﬁrm the recent data from a study by Pappone
et al21 in which no signiﬁcant differences were observed
between patients with and without ICM. However, despite
the fact that no signiﬁcant difference was observed between
LBBB and non-LBBB or between ICM and non-ICM, this
may be attributable to the small sample size and must be
conﬁrmed in larger prospective studies.Study limitations
This was an acute, single-center, nonrandomized study. The
number of patients was small but comparable to that of other
previous studies. Despite the small sample size, the robust
method of data analysis used endows our conclusions with
greater conﬁdence.
The patient population was not homogeneous in terms of
HF pathogenesis, QRS morphology, or presence of sinus
rhythm. Moreover, because this was an acute study, we do
not have any clinical data on follow-up.
The question of whether acute improvement in LV dP/
dtmax predicts long-term clinical beneﬁt is also controver-
sial. For all measurements, we used a ﬁxed AV and VVinterval, without optimization; this could be a limitation.
However, because our intention was to analyze the different
sites, we decided to limit these measurements so as not to
prolong the procedure.
The data from the present study need to be conﬁrmed in
larger prospective studies.Conclusion
MPP by means of a quadripolar LV lead in HF patients
undergoing CRT produced an adjunctive acute hemody-
namic beneﬁt in 26 of 29 patients (90%) compared with
traditional BiV pacing. In all patients, this acute hemody-
namic beneﬁt was found on pacing through all the available
veins at any LV site, even the worst. MPP elicited signiﬁ-
cantly greater QRS narrowing than conventional BiV pacing
at any site.Acknowledgments
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2015;26:58–63.CLINICAL PERSPECTIVES
Cardiac resynchronization therapy is a well-accepted therapy for patients with heart failure and electrical dyssynchrony.
Although it produces clear beneﬁts, one-third of patients do not beneﬁt from the therapy. Reasons for nonresponse include
clinical characteristics that are intrinsic to the patient, anatomic difﬁculties, the presence of phrenic nerve stimulation, high
pacing thresholds, left ventricular (LV) lead dislocation, and suboptimal positioning of the LV lead. The introduction of
quadripolar technology (an LV lead with 4 different pacing electrodes and a dedicated device with multiple pacing options)
could increase the effectiveness of cardiac resynchronization therapy, because it helps to avoid or signiﬁcantly reduce the
risk of phrenic nerve stimulation, high pacing threshold, and lead instability and could provide more effective
resynchronization by pacing the LV over a wider area. Our hypothesis was that the beneﬁt of multipoint pacing (MPP)
derived from better resynchronization. To study this, we systematically investigated the hemodynamic beneﬁt of MPP
performed at many pacing sites per heart and related the hemodynamic effect to both Q-LV and the reduction in QRS
duration. In our experience, MPP produced an adjunctive acute hemodynamic beneﬁt in 26 of 29 patients (90%) compared
with traditional biventricular pacing. In all patients, this acute hemodynamic beneﬁt was found on pacing through all the
available veins at any LV site, even the worst. MPP elicited signiﬁcantly greater QRS narrowing than conventional
biventricular pacing at any site.
